BRCA1 and ovarian cancer: Recently, a significantly higher mutation burden was detected by whole genome or exome sequencing in breast and ovarian cancer with mBRCA, compared with their counterparts carrying the wild-type BRCA1 and BRCA2 (wtBRCA) genes [14,15].